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regression) almost exclusively due to increased risk of periprocedural myocardial
infarction (MI) (1.6% vs. 0.2%; p=0.050), while the rates of cardiac death, spontaneous
MI, and target lesion revascluarization did not differ significantly between the two
groups.
Conclusion: The adjunctive use of IVUS during PCI in the EXCELLENT trial was
associated with more stents implanted, longer stenting, and bigger stenting. There were
no significant advantages of IVUS guidance regarding clinical outcome, but rather a
significant increase in periprocedural enzyme elevation, reflecting the more aggressive
procedures performed with IVUS guidance.
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Impact of Tissue Prolapse on Short- and Long-Term Clinical Outcomes after
Stent Implantation in Patients with Acute Myocardial Infarction: An
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Background: The impact of tissue prolapse (TP) on clinical outcomes after stent
implantation is still not well known. We used intravascular ultrasound (IVUS) to
evaluate the association of TP with short- and long-term clinical outcomes after stent
implantation in 418 acute myocardial infarction (AMI) patients (155 ST segment
elevation and 263 non-ST segment elevation MI).
Methods: TP was defined as tissue extrusion through the stent strut at post-stenting.
We evaluated the incidences of stent thrombosis, no-reflow, and long-term clinical
outcomes.
Results: After stenting, TP was detected in 34% without difference according to the
stent types. Acute and subacute stent thromboses occurred more frequently in patients
with TP compared with those without TP (3.5% vs. 0.7%, p=0.035, and 4.2% vs. 0.7%,
p=0.013, respectively). However, no significant difference was observed in the
incidence of late stent thrombosis between both groups. No-reflow was developed
more frequently in patients with TP compared with those without TP (25.4% vs. 9.8%,
p<0.001). Creatine kinase-MB and cardiac specific troponin-I were elevated more
significantly after stenting in patients with TP compared with those without TP
(+9.0±25.2 U/l vs. -4.2±41.6 U/l, p=0.001 and +10.0±43.5 ng/ml vs. -1.2±35.6 ng/ml,
p=0.005, respectively). There were no significant differences in the incidences of
cardiac death, MI, and target vessel revascularization at 1-year. Multivariate analysis
showed that TP was the independent predictor of composite of acute and subacute stent
thrombosis (OR=4.211; 95% CI 1.198-14.805, p=0.025) and composite of acute stent
thrombosis and no-reflow (OR=2.551; 95% CI 1.315-4.952, p=0.006).
Conclusion: TP was associated with short-term complications (acute and subacute
thrombosis and no-reflow phenomenon), however it was not affect long-term clinical
outcomes after stent implantation in patients with AMI.
TCT-106
Fate of Side Branches at 6, 12 and 24 months after implantation of
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Background: Fully bioresorbable everolimus-eluting vascular scaffolds (ABSORB,
Abbott Vascular, Santa Clara, USA) are a novel approach to treat coronary stenosis.
However the outcome of jailed side branch with ABSORB has not been investigated
yet. The purpose of this study is to assess the fate of struts covering the ostium of side-
branches at 6, 12 and 24 months after implantation of the BVS with three-dimensional
(3-D) optical coherence tomography (OCT) reconstruction.
Methods: The ABSORB Cohort B trial is a single-arm trial to assess the safety and
performance of the BVS. The first 45 patients (Group 1) underwent invasive imaging
at 6 months and at 2 years, while the remained 56 patients (Group 2) underwent
imaging follow-up at 1 and will repeat it at 3 years. FD-OCT imaging (C7XR system)
are obtained at a pullback speed of 20 mm/s.
Results: Paired 3D images at baseline and 6 months were available in 16 side branches,
while paired analysis at baseline and 12-month follow-up were available in 17 side
branches. At 6 months, the average ostium area free from jailing struts did not change
from baselines (BL: 1.73 ± 1.35 mm2, FU: 1.64 ± 1.21 mm2, p=0.7), and the number
of compartments was similar between baseline and 6 months following implantation
(BL: 2.07±1.1, 6M: 1.93±1.0, p=0.16). At 12 months, 3D OCT showed that
membranous tissue covers some struts, which was translated into a significant decrease
in the number of compartments from 2.1 ± 0.8 at baseline to 1.4 ± 0.85 at 12 months
(p=0.001). This was accompanied by a decrease in the strut-free ostial area (BL: 1.89
± 1.35 vs. 12M: 0.76 ± 1.98 mm2) without clinical implication.
Conclusion: The 3-D analysis showed that the ostial area free of struts remained
unchanged at 6 months compared to baseline, while it was reduced at 12 months due
to growing tissue covering the struts. The results of 2-year imaging will be presented
at the time of meeting.
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Background: Pathologic studies suggest that calcified coronary nodules account for
2-7% of thrombotic events. The frequency, distribution, predictors, and outcomes of
calcified nodules detected in vivo have never been described.
Methods: Following successful stenting in 697 patients with acute coronary syndromes
(ACS), three-vessel grayscale and virtual histology (VH) intravascular ultrasound
(IVUS) was performed. Based on histologic validation, an independent core lab
identified calcified nodule as irregular and convex plaque shape. Patients were followed
for three years.
Results: Overall, 314 calcified nodules were detected in 250 of 1573 analyzable
arteries (185 of 623 patients). Thus, the prevalence of calcified nodules was 17% per
artery and 30% per patient. The location of the calcified nodules were <40mm of the
ostium of the coronary artery in 85% of LAD and 86% of LCX while calcified nodules
within the RCA were evenly and more distally distributed. Patients with calcified
nodules were significantly older, had more plaque volume (IVUS), and more thick-
capped fibroatheroma (VH-IVUS), but fewer non-culprit lesion major adverse events
on follow-up.
Table. Clinical Characteristics, imaging parameters and clinical event rates
comparing patients with vs without calcified nodules
DC = dense calcium; NC = necrotic core
Conclusion: Calcified nodules in untreated non-culprit coronary segments in patients
with ACS are more prevalent than previously recognized; their distribution mirrors the
origin of most thrombotic events. However, they are unlikely to cause events during
3-year follow-up.
TCT-108
Intraoperative Shuntography for Immediate Control and Improvement of
Results of Coronary Bypass Surgery
Bagrat Alekyan, Leo Bockeria, Narek Zakarian, Anton Staferov, Karen Petrosian,
Andrey Abrosimov
Bakoulev Scientific Center for Cardiovascular Surgery, Moscow, Russian Federation
Background: To analyze our experience with intraoperative shuntography for
immediate evaluation of coronary shunts condition in patients after CABG.
Methods: The study comprised 1084 patients who received 2707 coronary shunts
during the period from February 2009 through April 2011. The patients’ age varied
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from 41 to 78 years (mean 59.7+4.3). Mean number of shunts per patient was 2,5. All
2707 shunts were distributed as follows: 977 (36%) autoarterial shunts using internal
mammary artery to the system of the left coronary artery (LAD and DB); 998 (37%)
autovenous shunts to the system of the left coronary artery (CxB, OMB, Intermedia,
DB, LAD); 732 (27%) autovenous shunts to the system of the right coronary artery.
Thus, autoarterial shunts were used in 36% and autovenous shunts – in 64% of cases.
In 672 (62%) cases the operations were performed under extracorporeal circulation,
and in 412 (38%) cases – on the beating heart.
Results: The problems in shunts or in shunted arteries were revealed in 289 (26,6%)
patients, hence, the rate of complications as calculated for the totality of shunts is
10,7%. In 153 (53%) cases the stenoses were revealed in the site of distal anastomosis
or the native artery beyond it the degree of stenosis varied from 50 to 90%. In 56 (19%)
cases the stenoses of mammaro-coronary shunt were revealed, in 40 (14%) – venous
shunt occlusions, in 24 (8%) – native artery occlusions and in 16 (6%) – mammaro-
coronary shunt occlusions. In 100 (34,6%) repeated interventions with subsequent
control shuntography were performed: in 9 (9%) the revealed lesion was corrected by
stenting, in 91 (91%) cases surgery was applied.
Conclusion: Intraoperative shuntography can reveal certain technical problems related
to immediate shunts performance, which can lead to early angina recurrence and shunts
occlusion in early postoperative period. Intraoperative solution of these problems
contributes to the improvement of immediate as well as of long-term results of
aortocoronary bypass surgery.
TCT-109
Arterial Response to Sirolimus Eluting Stents with Bioabsorbable Polymer:
First IVUS Report from the DESSOLVE-I FIM Trial
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Background: The MiStent consists of a cobalt chromium stent with a PLGA
bioabsorbable polymer and sirolimus, enabling complete drug elution and polymer
absorption within 90 days. DESSOLVE-I is a single-arm, multicenter, first-in-man
trial, enrolling 30 patients with follow-up at 4, 6, or 8 months (10 patients each) and
18 months (all). This study aimed to evaluate initial arterial response to MiStent in de
novo human coronary lesions.
Methods: In the 4-month cohort, volume index (VI: volume/length) was serially
obtained in 10 patients. Neointimal obstruction was calculated as neointima/stent
volume. Cross-sectional narrowing (CSN) was defined as neointima/stent area. Gross
coverage of struts was assessed as neointima-free frame ratio (number of frames
without neointima/total frame number).
Results: No significant changes were observed in vessel, plaque, or lumen VI during
follow-up. Neointima at 4 months was minimum, and no case showed significant
lumen encroachment. Neointima-free frame ratio was 20.2±16.6% (Cypher: 64±26%
and Xience: 39±27% at 8-9 months in historical database), indicating the large part of
the MiStent covered by neointima at 4 months. One case had late-acquired incomplete
stent apposition. There was no target lesion revascularization, cardiac death or stent
thrombosis.
Conclusion: Preliminary IVUS results from the first-in-man trial showed that the
MiStent with sirolimus and bioabsorbable polymer had rapid and uniform neointimal
coverage with no adverse vessel reaction. Follow-up of 6 and 8-month cohorts are
ongoing.
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Follow-Up of Patients with Ostium Secundum Atrial Septal Defect with Severe
Pulmonary Arterial Hypertension Undergoing Device Closure
Sudhir Chandra Sinha, Vipperla Sujatha
Department of Cardiology, Indus Hospitals, Visakhapatnam, India
Background: Device closure of Ostium Secundum Atrial Septal Defect (OSASD) is
done in patients with Pulmonary artery systolic pressure(PASP) less than 2/3rd of
systemic arterial systolic pressure(SASP).Little is known about device closure in
patients with OSASD who have PASP>2/3rd of SASP.
Methods: During August 2007 and December 2010, we attempted device closure of
94 patients,between age group 4years to 60 years.Out of 94, 9 patients had PASP >2/3
rd of SASP.We used our own clinical scoring system to identify patients for device
closure.All patients were pretreated with oral sildenafil for 3 weeks prior to planned
catheterization and device closure.
Results: All patients were females.the mean age was 42.5+/-11.5 years( Range 22-57
years).The mean PASP was 93.67 +/- 19.97 mmHg( range 72-140 mm Hg) and mean
SASP was 120.11 +/-13.20 mmHg(range106-160 mm Hg) .All patients had Qp:Qs >
1.5:1 and Rp/Rs <0.5. The mean follow -up PASP was 44.0+/-17.23 mmHg(range 30-
78 mmHg).More than 50% drop in PASP from baseline was noted in 7 out of 9 patients,
with PASP <45 mm Hg in 6 patients and 58 mmHg in 1 patient. Two patients had
significant fall in PASP though it remained 65 mm Hg in one patient and 78 mm Hg
in another patient.All patients improved from NYHA Class III to Asymptomatic or
functional class I.Three patients were noted to have additional respiratory component
contributing to the clinical picture.These patients showed dramatic improvement after
device closure. The patients received Sidenafil for 6 months or upto normalisation of
PASP. Sildenafil was not associated with improvement in clinical outcome.
Conclusion: Device closure in selected patients with OSASD and severe PAH is safe
and improves PASP,functional class and quality of life.
TCT-111
Mirgaine Visual Aura with or without Headache: Association with Right to Left
Shunt and Assessment Following Transcutaneous Closure
M. Khalid Mojadidi, Hamidreza Khessali, Rubine Gevorgyan, Ralph Levinson,
Jonathan Tobis
Interventional Cardiology, UCLA School of Medicine, Los Angeles, CA
Background: R to L shunting, usually caused by a patent foramen ovale (PFO), is
associated with migraine headache (MH) with aura. There are patients who present
with visual aura but deny headaches. It is unclear whether visual aura without headache
is a form of migraine (“visual migraine”) or is due to some other transient neurologic
dysfunction. This study assesses the prevalence of right to left (R to L) shunt in patients
presenting with visual aura and evaluates if aura resolves following closure of PFO.
Methods: Of 590 patients referred to UCLA for potential PFO related conditions, 225
patients had visual aura with or without MH. Patients were assessed for a R to L shunt
with Transcranial Doppler. They were evaluated for the presence of MH and/or visual
aura and then divided into three groups: 1) Group A (Aura + MH)- Aura during MH or
within 60 minutes of MH; 2) Group B (Aura unrelated to MH)- Aura not during MH
or within 60 minutes of MH; 3) Group C (Aura only)- visual aura without MH. The
frequency of R to L shunt was compared to a control group of 200 unselected patients
referred for diagnostic catheterization. 80 patients (approx. 1/3 per group) underwent
PFO closure. Residual MH and visual aura were assessed 12 months after the
procedure.
Results: The prevalence of R to L shunt in groups A, B, C and the control group were
96%, 72%, 67% and 18% respectively. The prevalence was similar in groups B vs. C
(p=0.66), but higher in group A due to selection bias. When compared to the control
group, the frequency of R to L shunt in all three groups was much higher (p<0.0001).
12 months after PFO closure, symptoms of visual aura were completely resolved in
52%, 75% and 80% of patients in groups A, B and C respectively (p=ns).
Conclusion: There is a strong correlation between PFO closure and improvement of
aura (with and without MH) suggesting a causative association between the presence
of PFO and the aura phenomenon. Since isolated visual aura has a similar prevalence
of R to L shunt and responds the same to PFO closure, it is likely similar in
pathophysiology to MH with aura.
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